BiomX News

10-Q: Quarterly report

May 20 17:26 ET

4: Statement of changes in beneficial ownership of securities-10% Owner OrbiMed Israel BioFund GP Limited Partnership

May 20 16:41 ET

4: Statement of changes in beneficial ownership of securities-10% Owner Cystic Fibrosis Foundation

May 17 16:12 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 15 17:11 ET

S-3: Registration statement for specified transactions by certain issuers

Apr 29 16:40 ET

BiomX | 3: Initial statement of beneficial ownership of securities-Director Blum Susan

Apr 15 19:30 ET

BiomX | 8-K: Current report

Apr 15 17:25 ET

BiomX | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 4 07:50 ET

BiomX | 10-K: Annual report

Apr 4 06:35 ET

BiomX | 8-K: BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Apr 3 07:42 ET

BiomX | NT 10-K: Others

Apr 1 16:10 ET

BiomX | D: Filing D

Apr 1 08:31 ET

BiomX | 3: Initial statement of beneficial ownership of securities-10% Owner Cystic Fibrosis Foundation

Mar 26 16:37 ET

BiomX | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cystic Fibrosis Foundation(15.6%)

Mar 26 16:37 ET

BiomX | SC 13G: Statement of acquisition of beneficial ownership by individuals-AMR Action Fund, L.P.(5.5%),AMR Action Fund GP, LLC(5.5%), etc.

Mar 25 15:39 ET

BiomX | SC 13D: Statement of acquisition of beneficial ownership by individuals-Deerfield Management Company, L.P.(11.06%),James E. Flynn(11.06%), etc.

Mar 22 17:48 ET

BiomX | 3: Initial statement of beneficial ownership of securities-Director Merril Gregory Louis

Mar 21 16:33 ET

BiomX | 3: Initial statement of beneficial ownership of securities-Director LEFF JONATHAN S

Mar 21 16:33 ET

BiomX | 3: Initial statement of beneficial ownership of securities-Director GOODMAN JESSE

Mar 21 16:32 ET

BiomX | 8-K/A: Current report (Amendment)

Mar 21 16:23 ET